IRA & Medicare drug price negotiation
Medicare Part D Premiums and Cost Sharing in 2027
KFFTopic alignment 88
Medicare Part D is a voluntary outpatient prescription drug benefit for people with Medicare provided through private plans, including stand-alone prescription drug plans and Medicare Advantage plans that offer drug coverage. This analysis provides an overview of Medicare Part D premiums and cost sharing in 2027 and key trends over time.
Filed under
CMS Issues Final Rule on the Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program
AMCP (Academy of Managed Care Pharmacy)Topic alignment 95
CMS finalizes rule to codify Medicare Drug Price Negotiation Program
AHATopic alignment 95
Most-Favored-Nation Drug Pricing Framework: How Manufacturer Agreements Affect Medicaid Best Price, Contracts, and Compliance
Frier LevittTopic alignment 90
How the Biosimilars Access and Affordability Act Redefines IRA Delays
The Center for BiosimilarsTopic alignment 92